Furthermore, in our study it was shown that the levels of hBD2 and hBD1 in patients with different kinds of cancer (without infection) were not significantly higher compared to the levels in patients with inflammation without cancer and without infection or healthy individuals. The gene discussed is DEFB1; the disease is cancer.